Lista de obras - Attilio Guarini - Dominio Público Uruguay

A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model

artículo científico publicado en 2017

A novel approach to evaluate blood parameters using computer vision techniques

scholarly article published May 2016

A supervised CAD to support telemedicine in hematology

A voluminous mass as an initial clinical symptom of multiple myeloma: A case report

artículo científico publicado en 2015

Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study.

artículo científico publicado en 2008

Antineoplastic drug-induced bradyarrhythmias.

artículo científico

Association between proteomic profile and molecular response in chronic myeloid leukemia patients

artículo científico publicado en 2017

Azacitidine in the treatment of older patients affected by acute myeloid leukemia: A report by the Rete Ematologica Pugliese (REP).

artículo científico publicado en 2015

Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a retrospective analysis

artículo científico publicado en 2014

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study.

artículo científico publicado en 2016

Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study

artículo científico publicado en 2012

Challenges and opportunities of microRNAs in lymphomas.

artículo científico publicado en 2014

Changes in angiogenesis and hypoxia-inducible factor-1α protein expression in relapsed/refractory indolent non-Hodgkin lymphomas

artículo científico publicado en 2013

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.

artículo científico publicado en 2016

Complete response to second line Paclitaxel every 2 weeks of eyelid kaposi sarcoma: a case report

artículo científico publicado en 2013

Dasatinib first-line: Multicentric Italian experience outside clinical trials

artículo científico publicado en 2015

Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma.

artículo científico publicado en 2012

Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma

scientific article published on 01 March 2008

FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities

artículo científico publicado en 2014

Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets

scientific article published on 03 October 2011

Frontline Dasatinib Treatment in a "Real-Life" Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia

artículo científico publicado en 2016

Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma

artículo científico publicado en 2009

HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target

artículo científico publicado en 2013

Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?

artículo científico

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

artículo científico publicado en 2009

Improving Provision of Care for Long-term Survivors of Lymphoma.

artículo científico publicado en 2017

Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma

artículo científico publicado en 2011

Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project

artículo científico publicado en 2018

Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines.

artículo científico

Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis.

artículo científico publicado en 2017

Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation

scientific article published on 01 April 2006

Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma

artículo científico publicado en 2016

Primary intracranial dural B cell small lymphocytic lymphoma

artículo científico publicado en 2007

Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.

artículo científico publicado en 2015

Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program.

artículo científico publicado en 2016

Synchronous Presentation of B-Cell Chronic Lymphocytic Leukemia/Small-Cell Lymphoma and Colon Adenocarcinoma Within the Same Mesenteric Lymph Nodes and a Single Liver Metastasis

artículo científico publicado en 2010

Targeted strategies in the treatment of primary gastric lymphomas: from rituximab to recent insights into potential new drugs.

artículo científico

The European accreditation of Istituto Tumori Giovanni Paolo II of Bari.

artículo científico publicado en 2015

Useful diagnostic biometabolic data obtained by PET/CT and MR fusion imaging using open source software

artículo científico publicado en 2014

We have a specific duty to maximise the safety of related donors

artículo científico publicado en 2012

Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma

article published in Hellenic journal of nuclear medicine

mTOR as a target of everolimus in refractory/relapsed Hodgkin lymphoma.

artículo científico

u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression

artículo científico publicado en 2017

Lista de obras de Attilio Guarini

A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model

A novel approach to evaluate blood parameters using computer vision techniques

A supervised CAD to support telemedicine in hematology

A voluminous mass as an initial clinical symptom of multiple myeloma: A case report

Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study.

Antineoplastic drug-induced bradyarrhythmias.

Association between proteomic profile and molecular response in chronic myeloid leukemia patients

Azacitidine in the treatment of older patients affected by acute myeloid leukemia: A report by the Rete Ematologica Pugliese (REP).

Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a retrospective analysis

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study.

Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study

Challenges and opportunities of microRNAs in lymphomas.

Changes in angiogenesis and hypoxia-inducible factor-1α protein expression in relapsed/refractory indolent non-Hodgkin lymphomas

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.

Complete response to second line Paclitaxel every 2 weeks of eyelid kaposi sarcoma: a case report

Dasatinib first-line: Multicentric Italian experience outside clinical trials

Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma.

Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma

FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities

Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets

Frontline Dasatinib Treatment in a "Real-Life" Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia

Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma

HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target

Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

Improving Provision of Care for Long-term Survivors of Lymphoma.

Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma

Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project

Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines.

Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis.

Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation

Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma

Primary intracranial dural B cell small lymphocytic lymphoma

Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.

Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program.

Synchronous Presentation of B-Cell Chronic Lymphocytic Leukemia/Small-Cell Lymphoma and Colon Adenocarcinoma Within the Same Mesenteric Lymph Nodes and a Single Liver Metastasis

Targeted strategies in the treatment of primary gastric lymphomas: from rituximab to recent insights into potential new drugs.

The European accreditation of Istituto Tumori Giovanni Paolo II of Bari.

Useful diagnostic biometabolic data obtained by PET/CT and MR fusion imaging using open source software

We have a specific duty to maximise the safety of related donors

Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma

mTOR as a target of everolimus in refractory/relapsed Hodgkin lymphoma.

u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression